Академический Документы
Профессиональный Документы
Культура Документы
Introdution
Pathophysiology
Intra-uterine
Extra-uterine
Stret
ch
Integrins
Inflammati
on
IL-1
TNF-
Abrupti
on
Thrombin
COX2
PGDH
PR-B
Stre
ss
CRH
Estrogen
MMPs
IL-6
and 8
PTL or PPROM
Principal biomechanical mechanisms responsible for chain pathways of
preterm parturition COX2=cyclooxygenase2, PGDH=prostaglandin dehydrogenase PRB=Progesteron receptorB.CRH=corticotropin releasing hormon MMPs=matrix metallo
proteinase
In: Creasy, Resnik . Maternal Fetal Medicine, 2009
Risk Factors(1)
Risk Factors(2)
Uterine causes
Myomata
Abnormal placentation
Risk Factors(3)
Infectious causes
Chorioamnionitis
Bacterial
vaginosis
Asymptomatic bacteriuria
Acute pyelonephritis
Cervical/vaginal colonization
Fetal causes
Intrauterine
fetal death
Intrauterine growth retardation
Congenital anomalies
Diagnosis
Documented uterine contractions(4 per 20
minutes or 8 per 60 minutes)
Documented cervical change (cervical
effacement of 80% or cervical dilatation of
2cm or more)
Forecast
uterine activity monitoring.
Ultrasound Examination of Cervical length
Fetal Fibronectin
PRETERM LABOR
Most mortality and
morbidity is
experienced by babies
born before 34 weeks
Treatment(1)
An initial assessment: ascertain cervical
length and dilatation and the station and
nature of the presenting part
Bed Rest : be placed in the lateral
decubitus position
Treatment(2)
Tocolytic therapy
Magnesium
Tocolytic Therapy
Prostaglandin
synthetase inhibitors:
indomethacin, administered both orally and
rectally
Ritodrine (Yutopar) Same as terbutaline
Nifedipine Indomethacin (Indocin)
Prostaglandin inhibitor
Beta-adrenergic agents
Hypokalemia
Hyperglycemia
Hypotension
Pulmonary edema
Arrhythmias
Cardiac insufficiency
Myocardial ischemia
Maternal death
Indomethacin (Indocin)
Renal failure
Hepatitis
Gastrointestinal bleeding
Nifedipine (Procardia)
Transient hypotension
Treatment(3)
Corticosteroid Therapy
Dexamethasone
and betamethasone
for fetal maturation reduces mortality, respiratory
distress syndrome and intraventricular hemorrhage
in infants between 28 and 34 weeks of gestation.
benefits start at 24 hours and last up to seven days
after treatment
The potential benefits or risks of repeated
administration of corticosteroids after seven days
are unknown.
Treatment(4)
Antibiotic Therapy
women
Treatment(5)
Premature of membrane
Definition
Incidence
PROM occurs in about 10-15% of all
delivery
PROM is associated with 10% of term
pregnancy
Cause of PROM(1)
Cause of PROM(2)
Cause of PROM(3)
Experimental Test(1)
The Nitrazine test uses pH to distinguish amniotic fluid
from urine and vaginal secretions, the paper turns dark
blue in response to the amniotic fluid
Amniotic fluid is quite alkaline having a pH above 7.0, but
vaginal secretions in pregnancy usually have pH values
of less 6.0
Experimental Test(2)
Risk of PROM
Preterm labor: 75%
Intrauterine infection(chorioamnionitis, 3050% of case)
Puerperal infection
Evaluation
Management(1)
Management(2)
Management(3)
If the gestational age is less 30 weeks,
vaginal deliverly should be chosen
If the fetus is significantlypreterm and the
absence of infection, expectant
management is generally chosen
Management(4)
tenderness daily
Electronic fetal monitoring used frequently
Fetal movement monitoring by the mother
Frequent ultrasound assessment helps to determine
amniotic fluid
Frequently WBC counts, usually daily for several days
Antibiotic should be used and antibiotic therapy may
prolong the latency period after preterm PROM and
improve the perinatal outcome
Management(5)
therapy (such as
betamethasone and dexamethasone) is
generally recommended in patients whose
gestational age is 34 weeks or less